Ozi ọma:

Bioantibody emechaala agba nke mbu nke ego ego ruru ihe ruru nde yuan 100.Fang Fund, New Industry Investment, Guoqian Venture Investment, bondshine isi obodo na Phoixe Tree Investment bụ aka duru ego a.
A ga-eji ego ahụ mee ka nhazi nke omimi nke Bioantibody dị ngwa na mbubata ngwa ngwa nwere ọgụgụ isi na nhazi nhazi na nhazi OEM / ODM nke ahaziri maka ọgwụ mgbochi, ngwaahịa #IVD, yana ọrụ teknụzụ metụtara wdg.

Bioantibody na-elekwasị anya na R&D, mmepụta na ire nke akụrụngwa akụrụngwa maka IVD na biopharmaceuticals.Dabere na mbụ elu-arụmọrụ ezubere iche maka hybridoma cell fusion technology na nkwado cell kwụsiri ike na-akpata na elu-throughput screening ikpo okwu, ụlọ ọrụ emepụtala ọtụtụ ngwaahịa na arụmọrụ tụnyere ma ọ bụ karịa nke ụwa mbụ IVD akụrụngwa akụrụngwa. , wee nweta azụmahịa nke ọma.Aghọtala ya nke ukwuu ma zụta ya ugboro ugboro site n'aka ndị ahịa nke ọtụtụ ụlọ ọrụ IVD ama ama nke edepụtara na China.

Bioantibody kemgbe mmalite ya nọgidere bụrụ eziokwu n'ọchịchọ mbụ ya, na-agbaso ihe ọhụrụ na-aga n'ihu na ọrụ nlekọta ahụike nke teknụzụ kwadoro.

Daalụ!!